Providing Healthcare for Everyone Everywhere

Jointown Pharmaceutical Group Co., Ltd.

Strive to build up the most professional comprehensive health service platform in China

More
billion RMB
Operating Income in 2024
billion RMB
Net Income Attributable to shareholders in 2024
billion RMB
Net Cash Flow in 2024
billion RMB
Total Assets ending Dec. 31, 2024
people
Employees
th
Chinese Private Enterprise
th
Chinese Private Enterprise in Service Industry
Sino-Securities Index ESG Ratings
Unit: RMB
Digital Pharmaceutical Distribution and Supply Chain Business
General Agency Brand Promotion Business
Pharmaceutical Industrial Self-production and OEM Business
Pharmaceutical New Retail & Ten-Thousand Store Alliance Plan Business
Medical Health and Technology Value-added Services
Digital Logistics and Supply Chain Solutions
Our Businesses

Digital Pharmaceutical Distribution and Supply Chain Business

More
Jointown provides upstream customers with full-channel and full-scenario digital distribution and promotion services, and downstream customers with "one-stop" full-variety digital supply chain services.
billion RMB
Sales Revenue in 2024
billion RMB
Gross Profit in 2024
+
Youngjoin Active Users
News Center

Company Dynamics And Industry Information

More
Corporate News
Improved operating performance quarter by quarter! Jointown's Q3 performance presentation held successfully
In the first three quarters of the year, Jointown's operating income, net profit attributable to the parent company, and net profit attributable to the parent company after deducting non-recurring profit and loss reached RMB 113.429 billion, RMB 1.696 billion and RMB 1.630 billion, respectively.
2024-11-01
More
Corporate News
Jointown Pre-REITs Fund Completes Fundraising, Attracting Subscriptions from Multiple Leading Financial Institutions
On April 16, Jointown announced that the Pre-REITs real estate private equity investment fund has completed registration and fundraising, with the initial capital of RMB 826 million fully paid in, laying a solid foundation for the company's subsequent asset securitization work.
2025-04-16
More
Media Coverage
State Council Policy Briefing Boosts Quality Improvement of Traditional Chinese Medicine, Laying a Quality Foundation for Heritage and Innovation to Jointly Shape a Blueprint for Development
On 21 March, the State Council Information Office held a routine policy briefing to explain the Opinions on Improving the Quality of Traditional Chinese Medicine and Promoting the High quality Development of the Traditional Chinese Medicine Industry. This policy is crafted with a top-level approach across all stages of the entire chain, proposing 21 tasks in 8 areas, focusing on improving quality, deepening reforms, and balancing tradition with innovation to inject strong momentum into the tradi
2025-03-24
More
Corporate News
Midas Touch: Jointown’s Two Data Assets Obtain Property Registration Certificates
On January 4, 2025, two data assets, under the name of Jointown Pharmaceutical Group Co., Ltd. (hereinafter referred to as "Jointown"), namely, "Smart Pharmaceutical Sales Recommendation Service" and "Pharmaceutical Market Insight Service Report", successfully obtained the data property registration certificate issued by Shenzhen Data Exchange, marking a new breakthrough in the registration of Jointown data property rights.
2025-01-07
More
Investor Relations

Stock Information

More
Jointown Pharmaceutical Group Co., Ltd. 600998.SH
5.44
-0.01 -0.18%
2025-06-13 16:29:06
Open 5.43
Previous Close 5.45
High 5.49
Low 5.36
Volume 33,849,487
Turnover 183,456,343RMB
Announcement
Q & A
ESG
Green development and technological empowerment create a sustainable future
Oriented by Green development and driven by innovation, we promote ESG practices through digitalization to create long-term value for the sustainable development of environment and society.
More

Jointown Service Platforms

Providing Healthcare for Everyone Everywhere

Jointown Pharmaceutical Group Co., Ltd.

Strive to build up the most professional comprehensive health service platform in China

billion RMB
Operating Income in 2024
billion RMB
Net Income Attributable to shareholders in 2024
billion RMB
Net Cash Flow in 2024
billion RMB
Total Assets ending Dec. 31, 2024
people
Employees
th
Chinese Private Enterprise
th
Chinese Private Enterprise in Service Industry
Sino-Securities Index ESG Ratings
Unit: RMB
More

Our Businesses

Digital Pharmaceutical Distribution and Supply Chain Business
Jointown provides upstream customers with full-channel and full-scenario digital distribution and promotion services, and downstream customers with "one-stop" full-variety digital supply chain services.
billion RMB
Sales Revenue in 2024
billion RMB
Gross Profit in 2024
+
Youngjoin Active Users
More
General Agency Brand Promotion Business
With its General Agency Brand Promotion (CSO) business moving into the fast lane, Jointown continues to build the "second curve" for profit growth, and upgrades the brand of "ALL WAYS ENGINE".
billion RMB
Sales Revenue in 2024
Product Specifications of Drugs
Product Specifications of Medical Devices
More
Pharmaceutical Industrial Self-production and OEM Business
Based on the existing varieties, brands, channels and marketing advantages, Jointown has conducted targeted development of self-operated industrial products and OEM business by virtue of big data accumulated by the Company's "hundred-billion-level" supply chain service platform. The business enjoys cluster development with respect to self-owned varieties.
billion RMB
Sales Revenue in 2024
billion RMB
Sales from Western Medicine Industry
billion RMB
Sales from TCM Industry
More
Pharmaceutical New Retail & Ten-Thousand Store Alliance Plan Business
Jointown focuses on the "Ten-Thousand Store Alliance Plan", and creates a business matrix that includes B2C e-commerce general agency sales and insurance performance, to develop a comprehensive, all-scenario "online and offline integrated" new retail service system directly targeting retail customers.
billion RMB
Sales to Franchised Pharmacies in 2024
Direct-Sale and Franchised Pharmacies
billion RMB
Sales from B2C E-commerce General Agency
More
Medical Health and Technology Value-added Services
Jointown continues to carry out independent development and provides customers with information technology-driven value-added services; it also advances the development of medical diagnosis services, enhances public health service capabilities, and extends the business to medical services, health management, medical technology and other comprehensive health fields, to create a comprehensive health service platform.
million RMB
Sales Revenue in 2024
Patent Rights of Technical Information
Software Copyright
More
Digital Logistics and Supply Chain Solutions
Relying on Jointown Cloud Warehouse, Jointown expands the third-party/fourth-party business and cold chain business, providing technology output and supply chain solutions.
billion RMB
Sales Revenue in 2024
million m²
GSP Warehouse (Excl. REITs & Pre-REITs)
Intelligent Logistics Patent
More

Company Dynamics And Industry Information

More
Corporate News
Improved operating performance quarter by quarter! Jointown's Q3 performance presentation held successfully
In the first three quarters of the year, Jointown's operating income, net profit attributable to the parent company, and net profit attributable to the parent company after deducting non-recurring profit and loss reached RMB 113.429 billion, RMB 1.696 billion and RMB 1.630 billion, respectively.
2024-11-01
Corporate News
Jointown Pre-REITs Fund Completes Fundraising, Attracting Subscriptions from Multiple Leading Financial Institutions
On April 16, Jointown announced that the Pre-REITs real estate private equity investment fund has completed registration and fundraising, with the initial capital of RMB 826 million fully paid in, laying a solid foundation for the company's subsequent asset securitization work.
2025-04-16
Media Coverage
State Council Policy Briefing Boosts Quality Improvement of Traditional Chinese Medicine, Laying a Quality Foundation for Heritage and Innovation to Jointly Shape a Blueprint for Development
On 21 March, the State Council Information Office held a routine policy briefing to explain the Opinions on Improving the Quality of Traditional Chinese Medicine and Promoting the High quality Development of the Traditional Chinese Medicine Industry. This policy is crafted with a top-level approach across all stages of the entire chain, proposing 21 tasks in 8 areas, focusing on improving quality, deepening reforms, and balancing tradition with innovation to inject strong momentum into the tradi
2025-03-24
Corporate News
Midas Touch: Jointown’s Two Data Assets Obtain Property Registration Certificates
On January 4, 2025, two data assets, under the name of Jointown Pharmaceutical Group Co., Ltd. (hereinafter referred to as "Jointown"), namely, "Smart Pharmaceutical Sales Recommendation Service" and "Pharmaceutical Market Insight Service Report", successfully obtained the data property registration certificate issued by Shenzhen Data Exchange, marking a new breakthrough in the registration of Jointown data property rights.
2025-01-07

Stock Information

More
Jointown Pharmaceutical Group Co., Ltd.
600998.SH
5.44
Open 5.43
Previous Close 5.45
Volume 33,849,487
2025-06-13 16:29:06
-0.01 -0.18%
High 5.49
Low 5.36
Turnover 183,456,343RMB
Announcement
Q & A
Green development and technological empowerment create a sustainable future
Oriented by Green development and driven by innovation, we promote ESG practices through digitalization to create long-term value for the sustainable development of environment and society.
More

Jointown Service Platforms